NovaGray’s Post

Danube Private University Austria (DPU) cooperates with EORTC - European Organisation for Research and Treatment of Cancer to develop research initiatives in radiology and therapy for meningiomas. EORTC (www.eortc.org) is a cancer research organization located in Brussels with almost 4000 members from over 50 different countries. Its key objective is to carry out international research projects and to improve the standard of cancer treatment for patients. In a recently signed cooperation project Univ.-Prof.in Priv.-Doz.in Dr.in Julia Furtner-Srajer, PhD MBA, Research Center for Medical Image Analysis and Artificial Intelligence (MIAAI), Danube Private University Austria (DPU) is involved in the planning and implementation of research focused on radiology and therapy for meningiomas. #research #researchcooperations #knowledgetransfer #science #scienceineurope #oncology #cancertreatment #cancerpatients #meningioma #radiology #therapy #healthcare #meidzinstudium #medicalstudies #studyinaustria #danubeprivateuniversity

📚 Structured Reporting Improves TNM Classification Accuracy and Radiologist Satisfaction 📚 In a collaborative multi-center study, Dr. Maurice Heimer and colleagues developed and validated a software-assisted #StructuredReporting (SR) framework for non-small cell lung cancer (NSCLC) staging using #mintLesion. 🔍 Key Insights: ✅ SR significantly improved TNM classification accuracy, reducing common errors in T-, N-, and M-staging compared to traditional free-text reports. ✅ Radiologists using SR were more likely to classify cases correctly and rated the tool highly for enhancing report quality, completeness, and interdisciplinary communication. ✅ This study suggests that SR may not only improve clinical accuracy but also support data standardization for future lung cancer research. This study highlights how SR not only advances clinical precision but also standardizes data collection, paving the way for large-scale research into lung cancer trends and outcomes. 🔗 Read more about it here: https://bit.ly/418TddB Get updates on expert insights and the latest studies using #mintLesion to transform medical research by following #ResearchWithMint. #LungCancer #Radiology #NSCLC #TNM

#AMCDiscoveries Researchers from Singapore General Hospital, National Cancer Centre Singapore (NCCS) and Duke-NUS Medical School investigated the effectiveness of combining two imaging techniques, multiparametric magnetic resonance imaging (mpMRI) and 68Ga-Prostate-specific membrane antigen (PSMA-11) positron emission tomography/computed tomography (PET/CT), to diagnose clinically significant prostate cancer (csPCa). They found that the combined approach significantly improves the detection of csPCa compared to using either modality alone. Specifically, when both imaging methods are able to detect suspicious lesions, the likelihood of csPCa is high. Read more in Cancers, MDPI: https://bit.ly/3yAto9Y AMC researchers involved: Joel Chin, Yu Guang Tan, Alvin Lee, Tze Kiat Ng, Ruoyu Shi, Charlene Yu Lin Tang, Sue Ping THANG, Jeffrey Tuan, Christopher Cheng, Kae Jack Tay, Henry HO, Winnie Lam (林穎泉), Yan Mee Law, John Shyi Peng Yuen, Kenneth Chen #AMRInews #research #Singapore #prostatecancer #imagingtechniques #SGH #NCCS #Duke-NUS #AMC Visit SingHealth Duke-NUS AM Research Institute (AMRI) at https://for.sg/aboutamri

The #ECR2024 congress is a great educational opportunity to experience real world evidence. Four topics devoted to MRI-guided transurethral ultrasound ablation (TULSA). Mark your calendars! 📆March 1, 14:00 - 15:30 CET - RPS 1507 👉Five-year outcomes after transurethral ultrasound ablation (TULSA) of localised prostate cancer 👨🏫Prof. Jurgen Fütterer / Nijmegen, Netherlands 📆March 2, 12:30 - 13:30 CET - RPS 1909 👉A single-center retrospective study of 300 men with localised primary prostate cancer treated using MRI-guided transurethral ultrasound ablation (TULSA). 👨🏫Dr. Lucas Engelage / Berlin, Germany 👉Twelve-month outcomes of salvage transurethral ultrasound ablation (TULSA) for the treatment of localised radio-recurrent prostate cancer 👨🏫Dr. Mikael Anttinen / Turku, Finland 👉12-month outcomes of MRI-guided transurethral ultrasound ablation (TULSA) for the treatment of benign prostatic hyperplasia 👨🏫Dr. Teija Sainio / Turku, Finland #interventionalradiology #radiology #profound #tulsapro #Prostatecancer

The UW Carbone Cancer Center is now home to the Initiative for Theranostics and Particle Therapy. This initiative will foster collaboration between experts across #medical #oncology, #radiation oncology, #radiology, nuclear #medicine, medical physics and other specialties to accelerate precision radiation #therapy and imaging for patients treated through the UW Health | Carbone Cancer Center. A key focus of the initiative will be translational research, or #research that is designed to benefit human #health. Investigators will assess how particle beam radiation may be effective to treat cancers that are difficult to treat using conventional radiation therapy, how diagnostic and #treatment steps can be combined into a single step referred to as theranostics, and how radiation treatment plans can be personalized for each patient. Article: 'New initiative for theranostics and particle therapy launched' https://lnkd.in/d9vXBiXB via the UW School of Medicine and Public Health #university #Wisconsin #cancer #innovation #precisionmedicine #health

Dear Partner, I hope this post finds you well. I wanted to share some exciting developments that P-Cure is advancing in the field of particle therapy, particularly around the potential use of dedicated synchrotrons for both protons and helium ions. While proton therapy has proven itself as a highly effective treatment for various cancers, peer-reviewed studies have shown that helium ions, due to their higher mass and reduced scattering in tissue, could offer even greater precision in targeting tumors while minimizing damage to surrounding healthy tissues. The idea that the same synchrotron infrastructure used for proton therapy can also be adapted to accelerate helium ions is truly promising. This dual-use approach could significantly enhance treatment versatility and precision, all while making the most of existing resources. It’s a fascinating concept, and I believe it could open the door to improved outcomes for patients in the near future. I’d love to hear your thoughts on this solution, and perhaps we could discuss how this might fit into your vision to advance cancer treatment. Looking forward to hearing from you. Warm regards, #ParticleTherapy #ProtonTherapy #HeliumIonTherapy #SynchrotronInnovation #CancerTreatment #PrecisionMedicine #RadiationOncology #MedicalInnovation #AdvancedTherapies #HealthcareTransformation American Society for Radiation Oncology (ASTRO) AAPM Student and Trainees Subcommittee American Society of Clinical Oncology (ASCO) PTCOG-NA The National Association for Proton Therapy European Society for Radiotherapy and Oncology (ESTRO) Elekta Philips Varian Siemens Healthineers P-Cure Ltd Aron Popovtzer Philip Blumenfeld Marcel Fang Jon Feldman Yair Hillman The Photo from a wonderful work of Marco Durante et al (2019).

"Protons at TU Delft: the HollandPTC consortium” is a colloquium by Coen Rasch, Medical Delta professor TU Delft and LUMC.   HollandPTC is the first clinical facility at the premises of the TU Delft. #Proton #radiation is a part of #radiotherapy. Per year 63.000 patients receive Radiotherapy of 119.000 new cancer diagnoses. Proton therapy is available in three centers in the Netherlands since 2018 and 1.200 patients per year receive proton therapy (i.e. 1%). By law the number is maximized at 1.600 patients per year. Holland PTC is a consortium of Delft University of Technology, Erasmus MC and Leiden University Medical Center.   Proton therapy aims at reducing side effects and is available for 9 different types of cancer. First clinical results are emerging, for example for the treatment of eye melanoma: Holland PTC saves 40 eyes per year.   As HollandPTC is a consortium of three universities there is an enormous potential for research and development. Examples of projects: - Real time flat Panel imaging - Enhanced immobilization for eye melanoma treatment - Cherenkov effect in vivo - Flash radiotherapy with protons, delivery in milliseconds Check out the portrait and video with Coen Rasch: "We are going to make the world's best eye radiation line”https://lnkd.in/eVtdqyBW #research #education #nuclear #proton #melanoma #cancer

We are delighted to announce that a recent qualitative research study conducted by MediPaCe’s own Sandeep Bagga, Natalie Swiderska, Charlotte Hooker has been published in the BMJ Open. A hallmark of qualitative research is its human-centred approach, making it inherently empathetic. Our study looked at breast cancer radiotherapy experiences and preferences and was guided from the very beginning by a patient-led Working Group who contributed to the research design, delivery and interpretation of findings. So, a big thank you to the members of this group: Siobhan Freeney Marie Ennis-O'Connor, Robin Woolcock Dympna Watson On the advice of the Working Group we incorporated a comparator arm, a unique and innovative approach within qualitative research design. This allowed for a robust comparison of the lived experiences and perspectives of patients (and caregivers) of TARGeted Intraoperative radioTherapy (TARGIT-IORT) with External-Beam RadioTherapy (EBRT). We would also like to thank ZEISS Medical Technology who provided unrestricted funding for this manuscript. Our co-sponsors played no part in the design, execution, interpretation or publication of this study. Click on the link below to review this open access manuscript and stay tuned for more discussions around the beauty of qualitative research. Paper available here: https://lnkd.in/eTbYSnxZ #PatientResearch, #PatientVoices, #QualitativeResearch, #BMJOpen, #ResearchPublished

A while back, I had the pleasure of leading an in-person workshop at LMU Klinikum München, where I guided attendees on using a structured reporting template for lung imaging used in the #BORN project of the Bayerisches Zentrum für Krebsforschung (BZKF). It’s great to see that the knowledge shared in this training is making an impact!   This recent multi-center study led by Dr. Maurice Heimer reveals the impact of #StructuredReporting in staging non-small cell lung cancer (NSCLC) — and the results are remarkable!   💡 Improved TNM Classification Accuracy: Radiologists using structured reporting were significantly more accurate in classifying #TNM stages compared to those using free-text reporting, crucial for ensuring patients receive the best-suited care. 💡 Semi-Automated Classification: The structured reporting framework integrates a rule-based engine that translates SR annotations into TNM classifications, minimizing errors and saving valuable time.   This study highlights strong evidence for SR’s benefits in #NSCLC staging, suggesting that wider adoption could drive more accurate, efficient cancer care.   Want to learn more? Don’t miss Maurice’s talk at #RSNA2024!   I’ll be in Chicago, too — let’s connect! If you’re interested in structured reporting or #mintLesion™, book a meeting with me here: https://bit.ly/4fLFYDC   #LungCancer #Radiology #Oncology

📣 Optellum Awarded Grant to Advance AI Imaging Technology 📣 💡 Optellum, a leading innovator in artificial intelligence (AI) and medical imaging for lung cancer, has secured joint funding from the NIHR (National Institute for Health and Care Research) and the Office for Life Sciences’ (OLS) new £148 million cancer programme to conduct a study on the impact of its AI product on early diagnosis of lung cancer. 🤝 In partnership with Leeds Teaching Hospitals NHS Trust, the study aims to evaluate the effectiveness of the AI product in relieving pressure on radiology departments and improving patient outcomes by enhancing diagnostic accuracy and supporting the early detection of cancers. 👉 Read the full release: https://lnkd.in/eWHeCSkt #LungHealth #Optellum #LungCancer